C, Z., X, Z., L, L., T, M., M, S., Y, Y., & Q, F. (2019). A small molecule inhibitor MCC950 ameliorates kidney injury in diabetic nephropathy by inhibiting NLRP3 inflammasome activation. Dove Medical Press.
Style de citation Chicago (17e éd.)C, Zhang, Zhu X, Li L, Ma T, Shi M, Yang Y, et Fan Q. A Small Molecule Inhibitor MCC950 Ameliorates Kidney Injury in Diabetic Nephropathy by Inhibiting NLRP3 Inflammasome Activation. Dove Medical Press, 2019.
Style de citation MLA (8e éd.)C, Zhang, et al. A Small Molecule Inhibitor MCC950 Ameliorates Kidney Injury in Diabetic Nephropathy by Inhibiting NLRP3 Inflammasome Activation. Dove Medical Press, 2019.
Attention : ces citations peuvent ne pas être correctes à 100%.